U.K. researchers develop experimental HIV vaccine; Pitt researchers target 'alphaviruses' with vaccines;

> the U.K. HIV Vaccine Consortium has developed an experimental HIV vaccine using a similar approach to that used to develop Ebola and malaria vaccines. News

> University of Pittsburgh researchers are working on drugs against "alphaviruses," a group of 30 viruses that are transmitted by mosquitoes. More

Suggested Articles

Having struck two COVID-19 vaccine supply deals already, EU officials are in discussions with Novavax, as well.

With its phase 3 trial moving right along, Moderna is expecting efficacy data in November—likely after Pfizer and BioNTech, but before everyone else.

BioNTech expects a quick turnaround once the transaction closes and plans to produce up to 250 million doses of BNT162b2 in the first half of 2021.